JCR Pharmaceuticals Co Ltd (4552)

Tokyo

Currency in JPY

667.0

+2.0(+0.30%)

Closed·07:30:29

Fair Value

Unlock Value

Day's Range

655.0

682.0

52 wk Range

386.0

765.0

4552 Income Statement

Featured here, the Income Statement (earnings report) for JCR Pharmaceuticals Co Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Period Ending:

2016

31/03

2017

31/03

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

2025

31/03

Total Revenues

aa.aa

30,085

51,082

34,343

42,871

33,072

Total Revenues Growth

aa.aa

+21.4%

+69.79%

-32.77%

+24.83%

-22.86%

Cost Of Revenues

aa.aa

7,812

10,461

8,886

11,620

11,333

Gross Profit

aa.aa

22,273

40,621

25,457

31,251

21,739

Gross Profit Growth

aa.aa

+31.95%

+82.38%

-37.33%

+22.76%

-30.44%

Gross Profit Margin %

aa.aa

74.03%

79.52%

74.13%

72.9%

65.73%

Other Operating Expenses, Total

aa.aa

13,984

20,686

20,480

23,719

28,580

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+2.56%	+47.93%	-1%	+15.82%	+20.49%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	5,360	7,175	8,802	11,234	15,431
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	8,624	13,511	11,678	12,485	12,958
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-

Operating Income

aa.aa

8,289

19,935

4,977

7,532

-6,841

Operating Income Growth

aa.aa

+155.44%

+140.5%

-75.03%

+51.34%

-190.83%

EBIT Margin %

aa.aa

27.55%

39.03%

14.49%

17.57%

-20.69%

Net Interest Expenses

aa.aa

-10

-8

Net Interest Expenses Growth

aa.aa

-145.45%

+270%

+200%

-115.69%

Interest Expense, Total

aa.aa

-42

-45

-44

-86

-155

Interest And Investment Income

aa.aa

137

147

Other Non Operating Expenses, Total

aa.aa

227

586

443

-321

-628

EBT, Excl. Unusual Items

aa.aa

8,506

20,511

5,437

7,262

-7,477

Gain (Loss) On Sale Of Assets

aa.aa

-5

-2

-36

-20

-2

Other Unusual Items, Total

aa.aa

129

-1,106

1,065

EBT, Incl. Unusual Items

aa.aa

8,652

19,403

5,411

7,242

-6,414

EBT, Incl. Unusual Items Growth

aa.aa

+152.91%

+124.26%

-72.11%

+33.84%

-188.57%

EBT, Incl. Unusual Items Margin

aa.aa

28.76%

37.98%

15.76%

16.89%

-19.39%

Income Tax Expense

aa.aa

1,764

4,886

1,625

1,707

-1,718

Net Income to Company

aa.aa

6,888

14,517

3,786

5,535

-4,696

Minority Interest

aa.aa

-10

-14

-28

-63

Net Income

aa.aa

6,892

14,507

3,772

5,507

-4,759

Net Income Growth

aa.aa

+157.36%

+110.49%

-74%

+46%

-186.42%

Net Income Margin %

aa.aa

22.91%

28.4%

10.98%

12.85%

-14.39%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

6,892

14,507

3,772

5,507

-4,759

Basic EPS - Continuing Operations

aa.aa

55.8

117.26

30.34

44.13

-38.43

Basic EPS - Continuing Operations Growth

aa.aa

+156.87%

+110.15%

-74.12%

+45.43%

-187.09%

Diluted EPS - Continuing Operations

aa.aa

55.53

116.8

30.22

43.92

-38.43

Diluted EPS - Continuing Operations Growth

aa.aa

+157.2%

+110.34%

-74.13%

+45.33%

-187.51%

Basic Weighted Average Shares Outstanding

aa.aa

123.52

123.72

124.31

124.79

123.83

Diluted Weighted Average Shares Outstanding

aa.aa

124.13

124.21

124.84

125.4

123.83

Dividend Per Share

aa.aa

11.5

Dividend Per Share Growth

aa.aa

+43.75%

+73.91%

EBITDA

aa.aa

10,181

21,880

6,974

10,729

-3,467

EBITDA Growth

aa.aa

+117.59%

+114.91%

-68.13%

+53.84%

-132.31%

EBITDA Margin %

aa.aa

33.84%

42.83%

20.31%

25.03%

-10.48%

EBIT

aa.aa

8,289

19,935

4,977

7,532

-6,841

* In Millions of JPY (except for per share items)

NSE 30

4,866.22

+2.63

+0.05%

NSE All Share

132,477.60

+25.87

+0.02%

US 30

44,699.50

+197.3

+0.44%

US 500

6,330.20

+20.6

+0.33%

FTSE 100

9,065.27

+41.46

+0.46%

DAX

24,144.14

+116.97

+0.49%

South Africa Top 40

92,487.74

+897.45

+0.98%

Market Movers

Name	Last	Chg. %	Vol.
Ellah Lakes	9.40	-5.05%	55.12M
Access Holdings	27.95	+1.64%	33.99M
UBA	46.85	+0.32%	7.92M
Guaranty Trust Holding	93.50	-0.32%	5.74M
Lafarge Africa	124.95	-0.83%	4.31M
Aradel Holdings	510.00	+2.00%	1.71M
Nestle Nigeria	1,950.00	+5.41%	197.47K

Name	Last	Chg. %	Vol.
Academy Press	7.70	+10.00%	257.87K
SCOA Nigeria	5.500	+10.00%	33.41K
Initiates	13.34	+9.98%	1.45M
Guinness Nigeria	106.45	+9.97%	15.96K
Ikeja	20.500	+7.33%	572.31K
Ncr Nigeria	7.98	+9.92%	302.00
Chellarams	10.47	+9.86%	50.80K

Name	Last	Chg. %	Vol.
Geregu Power	1,027.40	-10.00%	1.23K
Transcorp Power	288.00	-10.00%	47.75K
John Holt PLC	8.10	-10.00%	13.86K
Austin Laz	2.34	-10.00%	25.91K
Union Dicon Salt	9.00	-10.00%	294.22K
Conoil	211.10	-9.98%	4.17K
Livingtrust Mortgage Bank	6.59	-9.97%	500.00

Trending Stocks

Name	Last	Chg. %	Vol.
Aradel Holdings	510.00	+2.00%	1.71M
Guaranty Trust Holding	93.50	-0.32%	5.75M
Access Holdings	27.95	+1.64%	33.99M
Lafarge Africa	124.95	-0.83%	4.31M
Ellah Lakes	9.40	-5.05%	55.12M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaa	5,200.00	+37.70%	7,160.40
Aaaaaa	487.10	+25.64%	611.99
Aaaaaa A	66.20	+18.12%	78.20

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers

Popular Searches

Please try another search

JCR Pharmaceuticals Co Ltd (4552)

4552 Income Statement

Trending Stocks